您当前的位置：
首页 >
文章列表页 >
Systematic review of the safety of immune rechallenge after immune-related hepatitis
Drug and Clinical Practice | 更新时间：2026-10-28

    • Systematic review of the safety of immune rechallenge after immune-related hepatitis

    • Chin J Hosp Pharm   Vol. 46, Issue 17, Pages: 2000-2010(2026)

    • DOI：10.13286/j.1001-5213.2026.17.06    

      CLC： R969.3

    • Published：15 September 2026

    移动端阅览

  • LI Rongjie,HUANGFU Rui,HOU Kun,et al.Systematic review of the safety of immune rechallenge after immune-related hepatitis[J].Chin J Hosp Pharm,2026,46(17):2000-2010. DOI： 10.13286/j.1001-5213.2026.17.06.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Tetracyclines versus macrolides for childhood Mycoplasma pneumoniae pneumonia： a systematic review and meta‑analysis of efficacy and safety
Therapeutic efficacy and safety of potassium-competitive acid blockers for acid-related diseases： a Meta-analysis
Meta-analysis of the effect and safety of telmisartan in treatment of hypertension
Safety of exenatide for type 2 diabetes: a systematic review
Safety of saxagliptin for type 2 diabetes:a systematic review

Related Author

CHEN Yechao
SUN Yuhao
CHEN Dayu
ZHANG Haixia
YU Hongxiu
CHEN Ruixiang
YANG Yongcheng
LU Xikui

Related Institution

Department of Pharmacy， Nanjing Drum Tower Hospital， School of Basic Medicine and Clinical Pharmacy， China Pharmaceutical University
School of Basic Medicine and Clinical Pharmacy， China Pharmaceutical University
Department of Pharmacy， Nanjing Drum Tower Hospital， the Affiliated Hospital of Nanjing University Medical School
School of Pharmacy， Dali University， Yunnan Dali
Department of Pharmacy， Third People’s Hospital of Yunnan Province
0